GMAB:CPH
Genmab A/S
DKKÂ 2,285.00
arrow_upward
+0.35%(+8.00) 1D
Sep 28, 3:53:13 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
DKKÂ 2,304.00
High
DKKÂ 2,315.00
Low
DKKÂ 2,270.00
Mkt. cap
141.97B
Avg. vol.
109.87K
Volume
44.20K
52-wk high
DKKÂ 2,334.00
52-wk low
DKKÂ 1,512.00
Shares outstanding
62.41M
No. of employees
3K
Open
DKKÂ 2,304.00
High
DKKÂ 2,315.00
Low
DKKÂ 2,270.00
Mkt. cap
141.97B
Avg. vol.
109.87K
Volume
44.20K
52-wk high
DKKÂ 2,334.00
52-wk low
DKKÂ 1,512.00
Shares outstanding
62.41M
No. of employees
3K
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Genmab stock at DKK 2,277 on September 25, 2026, up 0.40 percent
The Globe and Mail
·
2 days ago
Genmab Grants New Employee Restricted Stock Units and Warrants
www.dars.gov.et
·
1 month ago
Genmab (GMAB) Edges Higher as Biotech Stock Holds Above Key Support - VWAP Bounce
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
FoundedJun 11, 1998
Headquarters-
SectorBiotechnology
Websitegenmab.com